Zepbound vs. Wegovy Trial - Search News

Order byBest matchMost fresh

News

Zepbound beats Wegovy for weight loss

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide,

Continue reading

· 3d · on MSN

Everyday Health on MSN · 1d

Zebound Beats Wegovy for Weight Loss in First Head-to-Head Trial

Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs

Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that ...

MedPage Today on MSN3d

Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results